What is I3LUNG
I3LUNG is a European project funded under the framework of the Horizon Europe (HEurope) call “Ensuring access to innovative, sustainable and high-quality health care”. Our consortium gathers 16 partners with different expertise located worldwide, with the common goal of providing better assistance and individualize treatment for patients affected by metastatic lung cancer.
For Patients
In the video below the project explained by Anne-Marie Baird, President of Lung Cancer Europe (LuCE) (one of the partners of the I3LUNG).
“We are excited to start this project which is envisioned to both generate novel therapeutic guidelines for clinical practice in lung cancer and support the growth of digital diagnostic tools in the European industry. (I3LUNG Partners)„
Find out the most relevant news on the latest advancements in lung cancer!
News
June, 26 2026
🚀 The countdown is on! In few days, the I3LUNG consortium comes together for our Annual Meeting, a key milestone […]
News
June, 25 2026
On Monday, Federica Corso (from our partner and project lead, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano) presented the […]
News
June, 1 2026
Two weeks ago at #CPDP2026 in Brussels, KU Leuven’s A. Halid Kayhan Kayhan, together with Eylem Karakaya and Francesco Trovò […]